Abstract 344: A high-throughput functional screen reveals synthetic lethal interactions associated with replication stress in HORMAD1-expressing triple-negative breast cancers

Author(s):  
Dalia Tarantino ◽  
Callum Walker ◽  
Daniel Weekes ◽  
Helen Pemberton ◽  
Jessica Frankum ◽  
...  
2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Sergi Guerrero Llobet ◽  
Bert van der Vegt ◽  
Evelien Jongeneel ◽  
Rico D. Bense ◽  
Mieke C. Zwager ◽  
...  

Abstract Replication stress entails the improper progression of DNA replication. In cancer cells, including breast cancer cells, an important cause of replication stress is oncogene activation. Importantly, tumors with high levels of replication stress may have different clinical behavior, and high levels of replication stress appear to be a vulnerability of cancer cells, which may be therapeutically targeted by novel molecularly targeted agents. Unfortunately, data on replication stress is largely based on experimental models. Further investigation of replication stress in clinical samples is required to optimally implement novel therapeutics. To uncover the relation between oncogene expression, replication stress, and clinical features of breast cancer subgroups, we immunohistochemically analyzed the expression of a panel of oncogenes (Cyclin E, c-Myc, and Cdc25A,) and markers of replication stress (phospho-Ser33-RPA32 and γ-H2AX) in breast tumor tissues prior to treatment (n = 384). Triple-negative breast cancers (TNBCs) exhibited the highest levels of phospho-Ser33-RPA32 (P < 0.001 for all tests) and γ-H2AX (P < 0.05 for all tests). Moreover, expression levels of Cyclin E (P < 0.001 for all tests) and c-Myc (P < 0.001 for all tests) were highest in TNBCs. Expression of Cyclin E positively correlated with phospho-RPA32 (Spearman correlation r = 0.37, P < 0.001) and γ-H2AX (Spearman correlation r = 0.63, P < 0.001). Combined, these data indicate that, among breast cancers, replication stress is predominantly observed in TNBCs, and is associated with expression levels of Cyclin E. These results indicate that Cyclin E overexpression may be used as a biomarker for patient selection in the clinical evaluation of drugs that target the DNA replication stress response.


2012 ◽  
Vol 209 (4) ◽  
pp. 679-696 ◽  
Author(s):  
Dai Horiuchi ◽  
Leonard Kusdra ◽  
Noelle E. Huskey ◽  
Sanjay Chandriani ◽  
Marc E. Lenburg ◽  
...  

Estrogen, progesterone, and HER2 receptor-negative triple-negative breast cancers encompass the most clinically challenging subtype for which targeted therapeutics are lacking. We find that triple-negative tumors exhibit elevated MYC expression, as well as altered expression of MYC regulatory genes, resulting in increased activity of the MYC pathway. In primary breast tumors, MYC signaling did not predict response to neoadjuvant chemotherapy but was associated with poor prognosis. We exploit the increased MYC expression found in triple-negative breast cancers by using a synthetic-lethal approach dependent on cyclin-dependent kinase (CDK) inhibition. CDK inhibition effectively induced tumor regression in triple-negative tumor xenografts. The proapoptotic BCL-2 family member BIM is up-regulated after CDK inhibition and contributes to this synthetic-lethal mechanism. These results indicate that aggressive breast tumors with elevated MYC are uniquely sensitive to CDK inhibitors.


2017 ◽  
Vol 114 (29) ◽  
pp. E5940-E5949 ◽  
Author(s):  
Xiaolei Pan ◽  
William C. Drosopoulos ◽  
Louisa Sethi ◽  
Advaitha Madireddy ◽  
Carl L. Schildkraut ◽  
...  

In the mammalian genome, certain genomic loci/regions pose greater challenges to the DNA replication machinery (i.e., the replisome) than others. Such known genomic loci/regions include centromeres, common fragile sites, subtelomeres, and telomeres. However, the detailed mechanism of how mammalian cells cope with the replication stress at these loci/regions is largely unknown. Here we show that depletion of FANCM, or of one of its obligatory binding partners, FAAP24, MHF1, and MHF2, induces replication stress primarily at the telomeres of cells that use the alternative lengthening of telomeres (ALT) pathway as their telomere maintenance mechanism. Using the telomere-specific single-molecule analysis of replicated DNA technique, we found that depletion of FANCM dramatically reduces the replication efficiency at ALT telomeres. We further show that FANCM, BRCA1, and BLM are actively recruited to the ALT telomeres that are experiencing replication stress and that the recruitment of BRCA1 and BLM to these damaged telomeres is interdependent and is regulated by both ATR and Chk1. Mechanistically, we demonstrated that, in FANCM-depleted ALT cells, BRCA1 and BLM help to resolve the telomeric replication stress by stimulating DNA end resection and homologous recombination (HR). Consistent with their roles in resolving the replication stress induced by FANCM deficiency, simultaneous depletion of BLM and FANCM, or of BRCA1 and FANCM, leads to increased micronuclei formation and synthetic lethality in ALT cells. We propose that these synthetic lethal interactions can be explored for targeting the ALT cancers.


2017 ◽  
Author(s):  
Subapriya Rajamanickam ◽  
Kaitlyn Bates ◽  
Santosh Timilsina ◽  
JunHyoung Park ◽  
Benjamin Onyeagucha ◽  
...  

Oncogene ◽  
2018 ◽  
Vol 37 (43) ◽  
pp. 5701-5718 ◽  
Author(s):  
Rachel Brough ◽  
Aditi Gulati ◽  
Syed Haider ◽  
Rahul Kumar ◽  
James Campbell ◽  
...  

Author(s):  
Madeleine Hewish ◽  
Chris J. Lord ◽  
Sarah A. Martin ◽  
David Cunningham ◽  
Alan Ashworth

Sign in / Sign up

Export Citation Format

Share Document